Prognostic Value of Posttherapy SPECT/CT for Overall Survival in Patients Undergoing [¹⁷⁷Lu]Lu-PSMA-617 Radiopharmaceutical Therapy: Results from 3 Clinical Trials.

已完结 20 由洋葱土豆发布于 2025/12/23 15:05:02

DOI:10.2967/jnumed.125.269640
作者：Raghava Kashyap,?James P Buteau,?Mathias Bressel,?Michal Eifer,?Neeraja Bollampally,?Price Jackson,?Lachlan McIntosh,?Shahneen Sandhu,?Michael S Hofman
文献类型：期刊论文
补充材料：只需要正文

其它数据库

Abstract：Data are emerging on the prognostic significance of quantitative changes on posttherapy SPECT/CT in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving [177Lu]Lu-

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:WileyCross-Dialect Emotion Recognition for Miners Based on Speech Feature Decoupling

Prognostic Value of Posttherapy SPECT/CT for Overall Survival in Patients Undergoing [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy: Results from 3 Clinical Trials.

Prognostic Value of Posttherapy SPECT/CT for Overall Survival in Patients Undergoing [¹⁷⁷Lu]Lu-PSMA-617 Radiopharmaceutical Therapy: Results from 3 Clinical Trials.